Gene · 92
Papers1,751
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 1,751
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Endometrial receptivity and implantation require uterine BMP signaling through an ACVR2A-SMAD1/SMAD5 axis. | Nat Commun | 2021 | 34099644 | PubTator, text mining | PubMed |
| Innovative Treatments for Rare Anemias. | Hemasphere | 2021 | 34095760 | PubTator, text mining | PubMed |
| Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma. | Diagnostics (Basel) | 2021 | 34070951 | PubTator, text mining | PubMed |
| Challenges of Neoantigen Targeting in Lynch Syndrome and Constitutional Mismatch Repair Deficiency Syndrome. | Cancers (Basel) | 2021 | 34067951 | PubTator, text mining | PubMed |
| Intra-Tumoral Genomic Heterogeneity in Rectal Cancer: Mutational Status Is Dependent on Preoperative Biopsy Depth and Location. | Cancers (Basel) | 2021 | 34065112 | PubTator, text mining | PubMed |
| Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma. | Biomed Res Int | 2021 | 34036102 | PubTator, text mining | PubMed |
| Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? | Front Oncol | 2021 | 34026645 | PubTator, text mining | PubMed |
| Distinct Genomic Landscape of Colorectal Mucinous Carcinoma Determined via Comprehensive Genomic Profiling: Steps to a New Treatment Strategy. | Front Oncol | 2021 | 34026601 | PubTator, text mining | PubMed |
| Histologic subtyping of ampullary carcinoma for targeted therapy. | J Pathol Transl Med | 2021 | 34015888 | PubTator, text mining | PubMed |
| Pathogenic ACVR1R206H activation by Activin A-induced receptor clustering and autophosphorylation. | EMBO J | 2021 | 34003511 | PubTator, text mining | PubMed |
| Differential Mutation Detection Capability Through Capture-Based Targeted Sequencing in Plasma Samples in Hepatocellular Carcinoma. | Front Oncol | 2021 | 33996539 | PubTator, text mining | PubMed |
| Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. | J Hepatol | 2021 | 33992698 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| MicroRNA Expression in Extracellular Vesicles from Nasal Lavage Fluid in Chronic Rhinosinusitis. | Biomedicines | 2021 | 33925835 | PubTator, text mining | PubMed |
| Discovering the Mutational Profile of Early Colorectal Lesions: A Translational Impact. | Cancers (Basel) | 2021 | 33923068 | PubTator, text mining | PubMed |
| Bone Morphogenetic Proteins and Diabetic Retinopathy. | Biomolecules | 2021 | 33919531 | PubTator, text mining | PubMed |
| Bioinformatic analysis linking genomic defects to chemosensitivity and mechanism of action. | PLoS One | 2021 | 33909629 | PubTator, text mining | PubMed |
| Gene expression analysis of MCF7 cell lines of breast cancer treated with herbal extract of Cissampelos pareira revealed association with viral diseases. | Gene Rep | 2021 | 33907720 | PubTator, text mining | PubMed |
| Letter to the Editor: Activin a Receptor Type 2A Mutation Affects the Tumor Biology of Microsatellite Instability-High Gastric Cancer. | J Gastrointest Surg | 2021 | 33904060 | PubTator, text mining | PubMed |
| De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer. | Front Oncol | 2021 | 33898315 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92/papers?page=28